Literature DB >> 1197382

Effects of several unusual sulfur-containing amino acids on rat liver cystathionine-gamma-lyase.

K Yao.   

Abstract

1. The mode of inhibition of rat liver cystathionine-gamma-lyase [L-cystathionine cysteine-lyase (deaminating), EC 4.4.1.1] was studied by using several unusual sulfur-containing amino acids newly found in this laboratory. Some cysteine conjugates (CMC, Beta-CEC, HCETC and HCPC) inhibited noncompetitively both homoserine dehydratase and diaminopropionate ammonia-lyase activities, and competitively gamma-cystathionase activity. CMTC exhibited a mixed type inhibition on both homoserine dehydratase and gamma-cystathionase activities, and a noncompetitive inhibition on the diaminopropionate ammonia-lyase activity. Some homocysteine conjugates (CMHC, beta-CEHC and HCEHC) inhibited competitively both the activity of homoserine dehydratase and of gamma-cystathionase, and exhibited a mixed type inhibition on the diaminopropionate ammonia-lyase activity. beta-CEC, CMHC and beta-CEHC were also effective inhibitors to cysteine desulfhydrase activity. 2. Among the other amino acids tested, DL-homocysteine and D-cysteine, irrespective of their concentration, exhibited a mixed type inhibition on the homoserine dehydratase activity. However, they promoted gamma-cystathionase activity at their lower concentrations and inhibited at their higher concentrations, more so than cystathionine. DL-alpha-Aminobutyric acid was a weak competitive inhibitor of the homoserine dehydratase, gamma-cystathionase and diaminopropionate ammonia-lyase activities. DL-alpha-Aminopimeric acid has the same chain length as beta-CEC, CMHC and CMTC, but it showed a very weak inhibitory effect compared with the latter sulfur-containing compounds. L-Methionine, DL-methionine sulfoxide, L-ethionine, L-cysteic acid, L-aspartic acid, L-asparagine, L-glutamic acid, L-glutamine, D-alanine, beta-alanine, L-ornithine and L-lysine had little or no effect on any activities of the enzyme preparation. These results were discussed in relation to the catalytic center of cystathionine-gamma-lyase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1197382

Source DB:  PubMed          Journal:  Physiol Chem Phys        ISSN: 0031-9325


  7 in total

Review 1.  Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy.

Authors:  Sumit Kar; Tyler N Kambis; Paras K Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

Review 2.  Homocysteine to hydrogen sulfide or hypertension.

Authors:  Utpal Sen; Paras K Mishra; Neetu Tyagi; Suresh C Tyagi
Journal:  Cell Biochem Biophys       Date:  2010-07       Impact factor: 2.194

Review 3.  A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator.

Authors:  Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-09-22       Impact factor: 5.858

4.  Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.

Authors:  Utpal Sen; Poulami Basu; Oluwasegun A Abe; Srikanth Givvimani; Neetu Tyagi; Naira Metreveli; Karan S Shah; John C Passmore; Suresh C Tyagi
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-27

Review 5.  H2S biosynthesis and catabolism: new insights from molecular studies.

Authors:  Peter Rose; Philip K Moore; Yi Zhun Zhu
Journal:  Cell Mol Life Sci       Date:  2016-11-14       Impact factor: 9.261

6.  Cystathionine β-synthase (CBS) deficiency suppresses erythropoiesis by disrupting expression of heme biosynthetic enzymes and transporter.

Authors:  Peng Zhao; Christopher Qian; Yun-Jin Chen; Yuan Sheng; Ya Ke; Zhong-Ming Qian
Journal:  Cell Death Dis       Date:  2019-09-24       Impact factor: 8.469

7.  Hydrogen Sulfide Ameliorates Homocysteine-Induced Cardiac Remodeling and Dysfunction.

Authors:  Sumit Kar; Hamid R Shahshahan; Tyler N Kambis; Santosh K Yadav; Zhen Li; David J Lefer; Paras K Mishra
Journal:  Front Physiol       Date:  2019-05-24       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.